WO2014006023A3 - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation Download PDF

Info

Publication number
WO2014006023A3
WO2014006023A3 PCT/EP2013/063897 EP2013063897W WO2014006023A3 WO 2014006023 A3 WO2014006023 A3 WO 2014006023A3 EP 2013063897 W EP2013063897 W EP 2013063897W WO 2014006023 A3 WO2014006023 A3 WO 2014006023A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical preparation
test
memory
early
lgt
Prior art date
Application number
PCT/EP2013/063897
Other languages
German (de)
French (fr)
Other versions
WO2014006023A2 (en
Inventor
Margot Schmitz
Original Assignee
Margot Schmitz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Margot Schmitz filed Critical Margot Schmitz
Priority to EP13753109.1A priority Critical patent/EP2866818A2/en
Publication of WO2014006023A2 publication Critical patent/WO2014006023A2/en
Publication of WO2014006023A3 publication Critical patent/WO2014006023A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

The invention relates to a pharmaceutical preparation comprising extracts or components of sesame and/or saffron for use as a drug. The invention permits the successful treatment of persons with early stage impairment in order to improve the memory capacity of a person who has tested positive in an LGT-3 learning and memory test and negative in a MOCA test. The invention thus prevents an early manifestation of the disease.
PCT/EP2013/063897 2012-07-02 2013-07-02 Pharmaceutical preparation WO2014006023A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP13753109.1A EP2866818A2 (en) 2012-07-02 2013-07-02 Pharmaceutical preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012211415.7 2012-07-02
DE102012211415.7A DE102012211415A1 (en) 2012-07-02 2012-07-02 Pharmaceutical preparation

Publications (2)

Publication Number Publication Date
WO2014006023A2 WO2014006023A2 (en) 2014-01-09
WO2014006023A3 true WO2014006023A3 (en) 2014-03-06

Family

ID=49035529

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/063897 WO2014006023A2 (en) 2012-07-02 2013-07-02 Pharmaceutical preparation

Country Status (3)

Country Link
EP (1) EP2866818A2 (en)
DE (1) DE102012211415A1 (en)
WO (1) WO2014006023A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100028474A1 (en) * 2008-07-28 2010-02-04 Thomas Eidenberger Sesame seed derived pigments
JP2010106001A (en) * 2008-10-31 2010-05-13 Theravalues Corp Ppar activator
US20100210572A1 (en) * 2009-02-18 2010-08-19 Thomas Eidenberger Hydrolysate of crocin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060021029A (en) * 2004-09-02 2006-03-07 경희대학교 산학협력단 Composition comprising sesamin having neuronal cell pretecting activity for preventing and treating the degenerative brain disease
DE102007040798A1 (en) * 2007-08-28 2009-04-02 Innovative Naturalsinc Herb mixture, useful e.g. to slow the aging process, comprises e.g. Crocus sativus, Elettaria cardamomum, Cinnamomum zeylanicum, Hedychium spicatum, Terminalia chebula, Trichosanthes dioica, Coleus forskolin and Berberis aristata
KR101139932B1 (en) * 2009-10-05 2012-04-30 목포대학교산학협력단 Neuroprotective agent comprising compounds extracted from defatted sesame seed

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100028474A1 (en) * 2008-07-28 2010-02-04 Thomas Eidenberger Sesame seed derived pigments
JP2010106001A (en) * 2008-10-31 2010-05-13 Theravalues Corp Ppar activator
US20100210572A1 (en) * 2009-02-18 2010-08-19 Thomas Eidenberger Hydrolysate of crocin
WO2010094745A1 (en) * 2009-02-18 2010-08-26 Omnica Gmbh Hydrolysate of crocin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 201035, Derwent World Patents Index; AN 2010-F18731, XP002714927 *

Also Published As

Publication number Publication date
WO2014006023A2 (en) 2014-01-09
EP2866818A2 (en) 2015-05-06
DE102012211415A1 (en) 2014-01-02

Similar Documents

Publication Publication Date Title
HK1213192A1 (en) Methods and devices for the treatment of ocular diseases in human subjects
IL260214A (en) Cell-based treatment and drug discovery in hirschsprung's disease enabled by pluripotent stem cell-derived human enteric neural crest lineages
BR112015002933A2 (en) implantable device for use in the human and / or animal body to replace an organ valve.
CR20150232A (en) IMIDAZO [1,2-A] PIRIDINCARBOXAMIDS AMINOSUSTITUIDAS AND ITS USE
BR112017018944A2 (en) method of treating a disease state or condition in humans with a carbinoid drug, and method of treating a disease state or condition in a mammal other than a human with carbinoid drug (s)
BR112014002718A2 (en) cell, cell population, pharmaceutical composition and kit for use in the treatment of a retinal degeneration disease
WO2016085632A3 (en) Microfluidic measurements of the response of an organism to a drug
PH12014501736A1 (en) Therapeutic use of p75ntr neurotrophin binding protein
EP3091074A4 (en) T cell receptor and b cell receptor repertoire analysis system, and use of same in treatment and diagnosis
PH12015500546A1 (en) Methods for increasing brain functionality using 2-fucosyl-lactose
BR112013007860A2 (en) methods and apparatus for restoring flow and implant limbs in the human body
EP3154533A4 (en) Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof
WO2013183058A3 (en) Expanded device
IL245738A0 (en) Oxindole derivatives, preparation thereof and therapeutic use in the treatment of ampk-related diseases
CL2014003525A1 (en) Pharmaceutical composition comprising fimasartan, hydrochlorothiazide and a binder; preparation procedure; its use in the treatment of hypertension.
ES2899185T8 (en) Probiotic strains that have cholesterol absorption capacity, procedures and uses thereof
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
IL238857B (en) Absorbant and reflecting biocompatible dyes for highly accurate medical implants
EP2774635A4 (en) Separation membrane for use in treatment of blood, and blood treatment device having said membrane integrated therein
EP3013425A4 (en) Treatment and diagnosis of ocular disease
HK1218115A1 (en) N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and n- (4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use n-(4--4--)-4-- n-(4--4--)- 4-(2-)
DK2859092T3 (en) THERAPEUTIC VACCINE FOR THE TREATMENT OF DIABETES TYPE-1 IN CHILDREN, USE OF CELL TYPES AND METHOD OF MULTIPLICATING SLOW CELLS FOR THE MANUFACTURE OF THERAPEUTIC VACCINE FOR THE BEHABETE VACCINE 1
DK2603238T3 (en) METHODS AND PHARMACEUTICAL PREPARATIONS FOR TREATING AN EYE DISEASE BY A PERSON
WO2014006023A3 (en) Pharmaceutical preparation
BR112015001595A2 (en) pharmaceutical composition, use of a roasted extract, and method for enhancing one or more therapeutic effect (s) of xantohumol and for the production of a pharmaceutical composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13753109

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2013753109

Country of ref document: EP